A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

Movement Disorders

Volumn 25, Issue 8, 2010, Pages 1077-1081

  Schrag, Anette ^a   Sheikh, Shamira ^a   Quinn, Niall P ^a   Lees, Andrew J ^a   Selai, Caroline ^a   Mathias, Chris ^a,b   Litvan, Irene ^c   Lang, Anthony E ^d   Bower, James H ^e   Burn, David J ^f   Low, Philip ^e   Jahanshahi, Marjan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e Mayo Clinic College of Medicine   (United States)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Anxiety; Depression; Health status; Multiple system atrophy; Parkinsonism; Progressive supranuclear palsy; Quality of life

Indexed keywords

AGED; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EQ 5D INDEX SCORE; FEMALE; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SCORING SYSTEM; SELF CARE; SHY DRAGER SYNDROME; COMPLICATION; FACTORIAL ANALYSIS; HEALTH SURVEY; MIDDLE AGED; NONPARAMETRIC TEST; PAIN MEASUREMENT; PSYCHOLOGICAL RATING SCALE;

AGED; ANXIETY; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 77953497720     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22794     Document Type: Article

References (25)

1. Benrud-Larson LM, Sandroni P, Schrag A, Low PA. Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 2005;20:951-957. (Pubitemid 41419509)
2. Schrag A, Geser F, Stampfer-KountchevM, et al. Health-related quality of life in multiple system atrophy.Mov Disord 2006;21: 809-815.
3. Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord 2003;18:1464-1469. (Pubitemid 38035369)
4. Schrag A, Selai C, Quinn N, et al. Measuring quality of life in PSP: the PSP-QoL. Neurology 2006;67:39-44.
5. Schrag A, Selai C, Mathias C, et al. Measuring health-related quality of life in MSA: the MSA-QoL. Mov Disord 2007;22: 2332-2338.
6. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
7. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
8. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007;130:1552-1565.
9. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112-1118.
10. Silva EG, Viana MA, Quagliato EM. Pain in Parkinson's disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 2008;66:26-29.
11. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008;65:1191-1194.
12. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009;80:24-28.
13. Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol 1999;246:893-898.
14. Tison F, Wenning GK, Volonte MA, Poewe WR, Henry P, Quinn NP. Pain in multiple system atrophy. J Neurol 1996;243: 153-156.
15. Esmonde T, Giles E, Gibson M, Hodges JR. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol 1996;243:638-643. (Pubitemid 26321008)
16. Borroni B, Turla M, Bertasi V, Agosti C, Gilberti N, Padovani A. Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr 2008;47:53-61. (Pubitemid 351763828)
17. Menza MA, Cocchiola J, Golbe LI. Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics 1995;36:550-554.
18. Fetoni V, Soliveri P, Monza D, Testa D, Girotti F. Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999; 66:541-544. (Pubitemid 29145696)
19. Gill CE, Khurana RK, Hibler RJ. Occurrence of depressive symptoms in Shy-Drager syndrome. Clin Auton Res 1999;9:1-4.
20. Muller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001;58:259-264. (Pubitemid 32163163)
21. Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy: a survey of the disease course. Neurology 1998;50: 1637-1647. (Pubitemid 28283229)
22. Nath U, Ben Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003;60:910-916. (Pubitemid 36348920)
23. Schrag A, Wenning GK, Quinn N, Ben Shlomo Y. Survival in multiple system atrophy. Mov Disord 2008;23:294-296.
24. Papapetropoulos S, Gonzalez J, Mash DC. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. Eur Neurol 2005;54:1-9. (Pubitemid 41328727)
25. Geser F, Wenning GK, Seppi K, et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006;21: 179-186.